Bridger Aerospace Announces Schedule for its Fourth Quarter 2023 Earnings Release and Conference Call – GlobeNewswire

BELGRADE, Mont., March 13, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (Bridger or Bridger Aerospace), (NASDAQ: BAER, BAERW), one of the nations largest aerial firefighting companies, today announced that it will release financial results for the fourth quarter and fiscal year ended December 31, 2023 on Tuesday, March 19, 2024 after the market close.

Management will conduct an investor conference call on Tuesday, March 19, 2024, at 5:00 p.m. Eastern Time (3:00 p.m. Mountain Time) to discuss these results and its business outlook. Interested parties can access the conference call by dialing 800-274-8461 or 203-518-9783. The conference call will also be broadcast live on the Investor Relations section of our website at https://ir.bridgeraerospace.com.

An audio replay will be available through March 26, 2024, by calling 844-512-2921 or 412-317-6671 and using the passcode 1155141. The replay will also be accessible at https://ir.bridgeraerospace.com.

About Bridger Aerospace Based in Belgrade, Montana, Bridger Aerospace Group Holdings, Inc. is one of the nations largest aerial firefighting companies. Bridger provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation, as well as internationally. More information about Bridger Aerospace is available at https://www.bridgeraerospace.com.

Investor Contacts Alison Ziegler Darrow Associates 201-220-2678 aziegler@darrowir.com

See the original post here:

Bridger Aerospace Announces Schedule for its Fourth Quarter 2023 Earnings Release and Conference Call - GlobeNewswire

Frontline Forum Part 1: Challenges and Opportunities to Enhance Psoriasis Management – Dermatology Times

As the understanding of psoriasis continues to evolve, the imperative of personalized care has gained prominence, reshaping the traditional paradigms of treatment. In the recentDermatology Timescustom video series Advancements in Psoriasis Care: Navigating Emerging Therapies and Guidelines, experts in the management of skin conditions discussed the latest developments in plaque psoriasis management. The panel discussion included Linda Stein Gold, MD, of Henry Ford Health in Detroit, Michigan; Mona Shahriari, MD, of Yale University School of Medicine in New Haven, Connecticut; Michael Cameron, MD, of Cameron Dermatology in New York, New York; Leon Kircik, MD, of Derm Research, PLLC, in Louisville, Kentucky; and George Han, MD, of Hofstra University in Hempstead, New York. The conversation shed light on the evolving paradigms, evidence-based approaches, and need for individualized care in managing thiscondition (Table).

Stein Gold emphasized the challenges posed by complex treatment regimens and said, The use of complex regimens with multiple topical agents can lead to lower adherence and less effective treatment. This sentiment underscores the critical need to streamline treatment approaches to enhance patient adherence and optimize treatment outcomes.

The panelists also highlighted the impact of treatment complexity on patient adherence, with Cameron noting, The more complex the regimen is, the lower the adherence, which means were less effectively [managing] the disease. This insight underscores the direct correlation between treatment complexity and patient adherence, emphasizing the need for streamlined andpatient-friendly regimens.

Furthermore, Shahriari said, Its really a matter of simplifying the treatment regimen. This sentiment underscores the need to reevaluate treatment approaches and streamline regimens to enhance patient adherence andtreatment efficacy.

In the realm of psoriasis management, the emergence of steroid phobia and evolving patient preferences has sparked critical discussions among health care professionals. Kircik highlighted the growing trend of steroid phobia among patients, stating, There is now this trend that nobody wants to be on steroids. This observation underscores the shifting attitudes toward steroid-based treatments and the impact on patient-provider discussions regarding treatment options.

The panelists also addressed the concerns surrounding patient preferences for nonsteroidal treatment options, with Stein Gold emphasizing the need to consider alternative therapies, stating, I think of steroids as a short-term solution to a long-term problem. Its really a Band-Aid. This sentiment underscores the evolving perspectives on steroid-based treatments and the need to explore nonsteroidal alternatives to address patient preferences and concerns. Additionally, Cameron provided insights into the prevalence of steroid phobia, saying, I find that [for] most of my patients, whether they [have] mild, moderate, or severe [disease], I dont want them using steroidslong term.

Psoriasis management guidelines serve as a critical resource, providing evidence-based recommendations for the management of psoriasis. Stein Gold addressed the limitations of current treatment guidelines and said, The problem is the guidelines are not for psoriasis. Theyre being done for atopic dermatitis right now. This observation sparked a conversation about the need for updated and comprehensive guidelines that align with the evolving landscape ofpsoriasis management.

The panelists also addressed the implications of treatment guidelines on patient care, with Kircik emphasizing the need for individualized treatment approaches, stating, We are looking for new topicals that are steroid freeor nonsteroidal.

Shahriari expressed the importance of defining disease severity in treatment guidelines and noted, I think we need to talk more about the definitions of mild, moderate, [and] severe psoriasis. This perspective highlights the need for clear and comprehensive definitions of disease severity to guide treatment approaches and optimize patient outcomes.

The panel noted that guidelines are often used against providers by attorneys and insurance companies and can be prescriptive rather than informative. The entire panel agreed that guidelines should be based on a review of the literature and provide a comprehensive overview of available treatments rather thanspecific recommendations.

See more here:

Frontline Forum Part 1: Challenges and Opportunities to Enhance Psoriasis Management - Dermatology Times

AI productivity tools can help at work, but some make your job harder – The Washington Post

In a matter of seconds, artificial intelligence tools can now generate images, write your emails, create a presentation, analyze data and even offer meeting recaps.

For about $20 to $30 a month, you can have the AI capabilities in many of Microsoft and Googles work tools now. But are AI tools such as Microsoft Copilot and Gemini for Google Workspace easy to use?

The tech companies contend they help workers with their biggest pain points. Microsoft and Google claim their latest AI tools can automate the mundane, help people who struggle to get started on writing, and even aid with organization, proofreading, preparation and creating.

Of all working U.S. adults, 34 percent think that AI will equally help and hurt them over the next 20 years, according to a survey released by Pew Research Center last year. But a close 31 percent arent sure what to think, the survey shows.

So the Help Desk put these new AI tools to the test with common work tasks. Heres how it went.

Ideally, AI should speed up catching up on email, right? Not always.

It may help you skim faster, start an email or elaborate on quick points you want to hit. But it also might make assumptions, get things wrong or require several attempts before offering the desired result.

Microsofts Copilot allows users to choose from several tones and lengths before you start drafting. Users create a prompt for what they want their email to say and then have the AI adjust based on changes they want to see.

While the AI often included desired elements in the response, it also often added statements we didnt ask for in the prompt when we selected short and casual options. For example, when we asked it to disclose that the email was written by Copilot, it sometimes added marketing comments like calling the tech cool or assuming the email was interesting or fascinating.

When we asked it to make the email less positive, instead of dialing down the enthusiasm, it made the email negative. And if we made too many changes, it lost sight of the original request.

They hallucinate, said Ethan Mollick, associate professor at the Wharton School of the University of Pennsylvania, who studies the effects of AI on work. Thats what AI does make up details.

When we used a direct tone and short length, the AI produced fewer false assumptions and more desired results. But a few times, it returned an error message suggesting that the prompt had content Copilot couldnt work with.

Using copilot for email isn't perfect. Some prompts were returned with an error message. (Video: The Washington Post)

If we entirely depended on the AI, versus making major manual edits to the suggestions, getting a fitting response often took multiple if not several tries. Even then, one colleague responded to an AI-generated email with a simple response to the awkwardness: LOL.

We called it Copilot for a reason, said Colette Stallbaumer, general manager of Microsoft 365 and future of work marketing. Its not autopilot.

Googles Gemini has fewer options for drafting emails, allowing users to elaborate, formalize or shorten. However, it made fewer assumptions and often stuck solely to what was in the prompt. That said, it still sometimes sounded robotic.

Copilot can also summarize emails, which can quickly help you catch up on a long email thread or cut through your wordy co-workers mini-novel, and it offers clickable citations. But it sometimes highlighted less relevant points, like reminding me of my own title listed in my signature.

The AI seemed to do better when it was fed documents or data. But it still sometimes made things up, returned error messages or didnt understand context.

We asked Copilot to use a document full of reporter notes, which are admittedly filled with shorthand, fragments and run-on sentences, and asked it to write a report. At first glance, the result seemed convincing that the AI had made sense of the messy notes. But with closer inspection, it was unclear if anything actually came from the document, as the conclusions were broad, overreaching and not cited.

If you give it a document to work off, it can use that as a basis, Mollick said. It may hallucinate less but in more subtle ways that are harder to identify.

When we asked it to continue a story we started writing, providing it a document filled with notes, it summarized what we had already written and produced some additional paragraphs. But, it became clear much of it was not from the provided document.

Fundamentally, they are speculative algorithms, said Hatim Rahman, an assistant professor at Northwestern Universitys Kellogg School of Management, who studies AIs impact on work. They dont understand like humans do. They provide the statistically likely answer.

Summarizations were less problematic, and the clickable citations made it easy to confirm each point. Copilot was also helpful in editing documents, often catching acronyms that should be spelled out, punctuation or conciseness, much like a beefed-up spell check.

With spreadsheets, the AI can be a little tricky, and you need to convert data to a table format first. Copilot more accurately produced responses to questions about tables with simple formats. But for larger spreadsheets that had categories and subcategories or other complex breakdowns, we couldnt get it to find relevant information or accurately identify the trends or takeaways.

Microsoft says one of users top places to use Copilot is in Teams, the collaboration app that offers tools including chat and video meetings. Our test showed the tool can be helpful for quick meeting notes, questions about specific details, and even a few tips on making your meetings better. But typical of other meeting AI tools, the transcript isnt perfect.

First, users should know that their administrator has to enable transcriptions so Copilot can interact with the transcript during and after the meeting something we initially missed. Then, in the meeting or afterward, users can use Copilot to ask questions about the meeting. We asked for unanswered questions, action items, a meeting recap, specific details and how we couldve made the meeting more efficient. It can also pull up video clips that correspond to specific answers if you record the meeting.

The AI was able to recall several details, accurately list action items and unanswered questions, and give a recap with citations to the transcript. Some of its answers were a little muddled, like when it confused the name of a place with the location and ended up with something that looked a little like word salad. It was able to identify the tone of the meeting (friendly and casual with jokes and banter) and censored curse words with asterisks. And it provided advice for more efficient meetings: For us that meant creating a meeting agenda and reducing the small talk and jokes that took the conversation off topic.

Copilot can be used during a Teams meeting and produce transcriptions, action items, and meeting recaps. (Video: The Washington Post)

Copilot can also help users make a PowerPoint presentation, complete with title pages and corresponding images, based off a document in a matter of seconds. But that doesnt mean you should use the presentation as is.

A documents organization and format seem to play a role in the result. In one instance, Copilot created an agenda with random words and dates from the document. Other times, it made a slide with just a persons name and responsibility. But it did better documents with clear formats (think an intro and subsections).

Google's Gemini can generate images like this robot. (Video: The Washington Post)

While Copilots image generation for slides was usually related, sometimes its interpretation was too literal. Googles Gemini also can help create slides and generate images, though more often than not when trying to create images, we received a message that said, for now were showing limited results for people. Try something else.

AI can aid with idea generation, drafting from a blank page or quickly finding a specific item. It also may be helpful for catching up on emails, meetings and summarizing long conversations or documents. Another nifty tip? Copilot can gather the latest chats, emails and documents youve worked on with your boss before your next meeting together.

But all results and content need careful inspection for accuracy, some tweaking or deep edits and both tech companies advise users verify everything generated by the AI. I dont want people to abdicate responsibility, said Kristina Behr, vice president of product management for collaboration apps at Google Workspace. This helps you do your job. It doesnt do your job.

And as is the case with AI, the more details and direction in the prompt, the better the output. So as you do each task, you may want to consider whether AI will save you time or actually create more work.

The work it takes to generate outcomes like text and videos has decreased, Rahman said. But the work to verify has significantly increased.

Continued here:

AI productivity tools can help at work, but some make your job harder - The Washington Post

Patients’ perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare … – Nature.com

Prince AE, Cadigan RJ, Henderson GE, Evans JP, Adams M, Coker-Schwimmer E. et al. Is there evidence that we should screen the general population for Lynch syndrome with genetic testing? A systematic review. Pharmacogenomics Pers Med.2017;10:4960.

CAS Google Scholar

Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. Risk Assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: updated evidence report and systematic review for the US Preventive Services Task Force. Jama. 2019;322:66685.

Article PubMed Google Scholar

Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2020;69:41144.

Article CAS PubMed Google Scholar

Young AL, Imran A, Spoelma MJ, Williams R, Tucker KM, Halliday J, et al. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review. Eur J Hum Genet. 2023;31:1834.

Article CAS PubMed Google Scholar

Ahsan MD, Levi SR, Webster EM, Bergeron H, Lin J, Narayan P, et al. Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC Innov. 2023;2:100138.

Article PubMed PubMed Central Google Scholar

Gaff CL, Collins V, Symes T, Halliday J. Facilitating family communication about predictive genetic testing: probands perceptions. J Genet Couns. 2005;14:13340.

Article PubMed Google Scholar

Frey MK, Ahsan MD, Bergeron H, Lin J, Li X, Fowlkes RK, et al. Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis. J Clin Oncol. 2022;40:412943.

Article PubMed PubMed Central Google Scholar

Menko FH, van der Velden SL, Griffioen DN, Ait Moha D, Jeanson KN, Hogervorst FBL, et al. Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation. J Genet Couns. 2023 [Internet]. Aug 21. Available from: https://www.ncbi.nlm.nih.gov/pubmed/37605508.

National clinical guidelines of breast cancer management [Internet]. Confederation of Regional Cancer Centres in Sweden. [cited 2023 Sept 10]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/brostcancer/vardprogram/.

National clinical guidelines of colorectal cancer management [Internet]. Confederation of Regional Cancer Centres in Sweden. [cited 2023 Sept 10]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/tjock-och-andtarmscancer/vardprogram/.

Hawranek C, Ehrencrona H, Ofverholm A, Hellquist BN, Rosen A. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study). Trials. 2023;24:810.

Article PubMed PubMed Central Google Scholar

Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport, Exerc Health. 2019;11:58997.

Article Google Scholar

Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77101.

Article Google Scholar

Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003;64:31726.

Article CAS PubMed Google Scholar

Gaff CL, Clarke AJ, Atkinson P, Sivell S, Elwyn G, Iredale R, et al. Process and outcome in communication of genetic information within families: a systematic review. Eur J Hum Genet. 2007;15:9991011.

Article PubMed Google Scholar

McGarragle KM, Hare C, Holter S, Facey DA, McShane K, Gallinger S, et al. Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study. Hered Cancer Clin Pr. 2019;17:16.

Article Google Scholar

Henrikson NB, Blasi P, Figueroa Gray M, Tiffany BT, Scrol A, Ralston JD, et al. Patient and family preferences on health system-led direct contact for cascade screening. J Pers Med. 2021;11:538.

Article PubMed PubMed Central Google Scholar

Pedrazzani C, Aceti M, Schweighoffer R, Kaiser-Grolimund A, Brki N, Chappuis PO, et al. The communication chain of genetic risk: analyses of narrative data exploring probandprovider and probandfamily communication in hereditary breast and ovarian cancer. J Pers Med. 2022;12:1249.

Article PubMed PubMed Central Google Scholar

Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC. Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. 2020;28:163144.

Article PubMed PubMed Central Google Scholar

Daly MB. Family communication of genetic risk: a personalized approach. Curr Genet Med Rep. 2016;4:3540.

Article Google Scholar

Finn KS, Pacyna J, Azevedo Tsou C, Jewel Samadder N, Sharp R. Patient-reported anticipated barriers and benefits to sharing cancer genetic risk information with family members. Eur J Hum Genet. 2022;30:5361.

Article PubMed Google Scholar

Srinivasan S, Hampel H, Leeman J, Patel A, Kulchak Rahm A, Reuland DS, et al. Stakeholder perspectives on overcoming barriers to cascade testing in Lynch syndrome: a qualitative study. Cancer Prev Res. 2020;13:103746.

Article Google Scholar

Ballard LM, Band R, Lucassen AM. Interventions to support patients with sharing genetic test results with at-risk relatives: a synthesis without meta-analysis (SWiM). Eur J Hum Genet. 2023;31:9881002.

Article PubMed PubMed Central Google Scholar

Mendes A, Paneque M, Sousa L, Clarke A, Sequeiros J. How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence. Eur J Hum Genet. 2016;24:31525.

Article PubMed Google Scholar

Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A. A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Fam Cancer. 2011;10:8796.

Article PubMed Google Scholar

Jacobs C, Dancyger C, Smith JA, Michie S. Accuracy of recall of information about a cancer-predisposing BRCA1/2 gene mutation among patients and relatives. Eur J Hum Genet. 2015;23:14751.

Article CAS PubMed Google Scholar

van den Heuvel LM, Hoedemaekers YM, Baas AF, Baars MJH, van Tintelen JP, Smets EMA, et al. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial. Eur J Hum Genet. 2022;30:20310.

Article PubMed Google Scholar

Jacobs C, Patch C, Michie S. Communication about genetic testing with breast and ovarian cancer patients: a scoping review. Eur J Hum Genet. 2019;27:51124.

Article PubMed Google Scholar

van den Heuvel LM, Smets EMA, van Tintelen JP, Christiaans I. How to inform relatives at risk of hereditary diseases? A mixed-methods systematic review on patient attitudes. J Genet Couns. 2019;28:104258.

Article PubMed Google Scholar

Eijzenga W, de Geus E, Aalfs CM, Menko FH, Sijmons RH, de Haes H, et al. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial. Patient Educ Couns. 2018;101:16119.

Article PubMed Google Scholar

Pedrazzani C, Ming C, Burki N, Caiata-Zufferey M, Chappuis PO, Duquette D, et al. Genetic literacy and communication of genetic information in families concerned with hereditary breast and ovarian cancer: a cross-study comparison in two countries and within a timeframe of more than 10 years. Cancers. 2021;13:6254.

Article PubMed PubMed Central Google Scholar

Paul J, Metcalfe S, Stirling L, Wilson B, Hodgson J. Analyzing communication in genetic consultations-a systematic review. Patient Educ Couns. 2015;98:1533.

Article PubMed Google Scholar

Henrikson NB, Blasi PR, Fullerton SM, Grafton J, Leppig KA, Jarvik GP, et al. It would be so much easier: health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system. J Community Genet. 2019;10:46170.

Article PubMed PubMed Central Google Scholar

Dheensa S, Fenwick A, Lucassen A. Is this knowledge mine and nobody elses? I dont feel that. Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Eth. 2016;42:1749.

Article Google Scholar

Tam NT, Huy NT, Thoa le TB, Long NP, Trang NT, Hirayama K, et al. Participants understanding of informed consent in clinical trials over three decades: systematic review and meta-analysis. Bull World Health Organ. 2015;93:18698H.

Article PubMed PubMed Central Google Scholar

Blasi PR, Scrol A, Anderson ML, Gray MF, Tiffany B, Fullerton SM, et al. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation. Pilot Feasibility Stud. 2022;8:174.

Article PubMed PubMed Central Google Scholar

Kim S, Aceti M, Baroutsou V, Burki N, Caiata-Zufferey M, Cattaneo M, et al. Using a Tailored Digital Health Intervention for family communication and cascade genetic testing in Swiss and Korean families with hereditary breast and ovarian cancer: protocol for the DIALOGUE study. JMIR Res Protoc. 2021;10:e26264.

Article PubMed PubMed Central Google Scholar

Siglen E, Vetti HH, Augestad M, Steen VM, Lunde A, Bjorvatn C. Evaluation of the Rosa chatbot providing genetic information to patients at risk of hereditary breast and ovarian cancer: qualitative interview study. J Med Internet Res. 2023;25:e46571.

Article PubMed PubMed Central Google Scholar

Read more from the original source:

Patients' perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare ... - Nature.com

Global $83.7 Bn Cloud Computing Management and Optimization Market to 2030 with IT and Telecommunications … – PR Newswire

DUBLIN, Jan. 23, 2024 /PRNewswire/ -- The"Global Cloud Computing Management and Optimization Market 2023 - 2030 by Types, Applications - Partner & Customer Ecosystem Competitive Index & Regional Footprints" report has been added to ResearchAndMarkets.com's offering.

The Cloud Computing Management and Optimization Market size is estimated to grow from USD 17.6 Billion in 2022 to reach USD 83.7 Billion by 2030, growing at a CAGR of 21.7% during the forecast period from 2023 to 2030.

The Adoption of Cloud Based Solution Is Drive the Cloud Computing Management and Optimization Market Growth

As businesses migrate their operations to cloud-based ecosystems, as it offers a number of benefits, such as scalability, flexibility, and cost savings. A growing number of companies are adopting cloud computing includingSMEs and Large scale companies, which will lead to an increase in demand for cloud computing management and optimisation solutions.

Cloud computing environments are becoming increasingly complex, as businesses adopt a variety of cloud services from different providers. This complexity can make it difficult for businesses to manage their cloud costs and performance. Cloud computing management and optimization solutions can help businesses to simplify their cloud environments and optimize their costs and performance. Cloud computing can be a cost-effective way for businesses to IT resources.

However, businesses can still incur significant costs if they do not manage their cloud usage effectively. Cloud computing management and optimization solutions can help businesses to track their cloud usage and identify opportunities to optimize their costs. The cloud computing industry is constantly evolving, with the emergence of new technologies, such as artificial intelligence and machine learning. These new technologies can be used to improve the efficiency and effectiveness of cloud computing management and optimization solutions.

The IT and Telecommunications industries hold the highest market share in the Cloud Computing Management and Optimization Market

The IT and Telecommunications industries hold the highest market share in the Cloud Computing Management and Optimization Market in 2022, due to their intrinsic reliance on advanced technology solutions and their pivotal role in driving digital transformation across various sectors. In the IT industry, cloud computing has become a cornerstone for delivering software, platforms, and infrastructure services, enabling organizations to enhance agility, scalability, and operational efficiency.

As IT companies transition their operations to the cloud, the need for effective management and optimization of cloud resources becomes paramount to ensure optimal performance, cost control, and resource allocation. Cloud management and optimization solutions enable IT enterprises to streamline provisioning, monitor workloads, automate processes, and maintain stringent security protocols.

Furthermore, the Telecommunications sector has embraced cloud computing to modernize and expand its network infrastructure, offer innovative communication services, and adapt to the demands of an interconnected world. Cloud-based solutions empower telecom companies to efficiently manage network resources, deliver seamless customer experiences, and explore new revenue streams.

In this context, cloud computing management and optimization are essential for maintaining network reliability, ensuring data privacy, and dynamically scaling resources to meet fluctuating demand. The complex and dynamic nature of both IT and Telecommunications operations necessitates sophisticated tools and strategies for cloud resource management, making these industries prime contributors to the Cloud Computing Management and Optimization Market

Regional Insight: North America dominated the Cloud Computing Management and Optimization Market during the forecast period.

North America dominated the Cloud Computing Management and Optimization Market during the forecast period. Cloud computing has been continuously adopted by the United States and Canada, which are at the forefront of technological development, which helps strengthen North America's remarkable position as market leader. The strong presence of major companies like Adobe, Salesforce, Oracle,AWS, Google, and IBM inside the region's wide geography provides a foundation for this rise. With their cutting-edge solutions, these major players make a significant impact on adoption and innovation.

The region's commitment to technical advancement also serves as another indication of its dominance. Continuous improvements in a number of technologies are transforming the cloud computing industry, and North America is recognized as a hub for important developments.

As a result, organizations and enterprises in North America are pushed to the forefront of cloud optimization and administration, utilizing the full range of technologies and expertise provided by both local and international industry experts. Strong vendor presence, widespread acceptance, and constant technological innovation place North America in the lead for snatching the highest market share during the forecast period.

Major Classifications are as follows:

Cloud Computing Management and Optimization Market, Type of Solutions

Cloud Computing Management and Optimization Market, By Deployment Models

Cloud Computing Management and Optimization Market, By Organization Size

Cloud Computing Management and Optimization Market, By Cloud Service Models

Cloud Computing Management and Optimization Market, By Technologies

Cloud Computing Management and Optimization Market, By Industries

Cloud Computing Management and Optimization Market, By Geography

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/bx3846

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

Read this article:

Global $83.7 Bn Cloud Computing Management and Optimization Market to 2030 with IT and Telecommunications ... - PR Newswire

COVID increases risk of schizophrenia? Read what a new study has found – IndiaTimes

COVID cases are increasing globally. India recorded more than 4,400 COVID cases as on Friday. Cases of COVID have been increasing in the country ever since the first case of JN.1 variant was detected in Kerala. The JN.1 variant, an offshoot of the BA.2.86 variant is currently responsible for more than 60% of COVID cases in the US. In view of the emerging variants of the COVID-causing coronavirus, it is essential to know about the effects of the virus on the human body. A new study has shed light on the effect of COVID on the cognitive function of the brain. The study, not peer-reviewed yet, found a substantial increase in the likelihood of being diagnosed with a schizophrenia spectrum and psychotic disorder (SSPD) after experiencing moderate to severe illness due to SARS-CoV-2 infection, in comparison to a group of individuals who had non-Covid Acute Respiratory Distress Syndrome (ARDS). Our study is consistent with the known neurotropism of the SARS-CoV-2 virus and other reports of increased risk of major psychiatric disorders following Covid-19 infection, said Asif Rahman, from the Department of Industrial & Management Systems Engineering, West Virginia University. Further research is required to identify specific characteristics of populations and individuals who may be at a particularly high risk of developing SSPD and potentially other significant psychiatric conditions following Covid-19 infection. Understanding these psychiatric risks associated with Covid-19 is an essential component of our strategy to address the evolving landscape of long-Covid, added Rahman, in the paper posted on a preprint site. Schizophrenia is a severe mental disorder characterized by distorted thinking, disrupted emotions, and abnormal perceptions of reality. It typically manifests in early adulthood, impacting a person's ability to function in daily life. Common symptoms include hallucinations (false sensory perceptions), delusions (false beliefs resistant to reason), disorganized thinking, and impaired social or occupational functioning. Long-term high fat diets linked to increased risk of COVID, finds study The exact cause of schizophrenia is unclear, but a combination of genetic, environmental, and neurobiological factors likely contribute. Genetic predisposition, neurotransmitter imbalances (particularly involving dopamine), and structural brain abnormalities are implicated. Subtypes of schizophrenia exist, with paranoid, disorganized, catatonic, residual, and undifferentiated forms identified. Treatment often involves antipsychotic medications to manage symptoms, therapy to enhance coping skills and social functioning, and support from mental health professionals, family, and friends. While medication can help control symptoms, the course of schizophrenia varies, and individuals may experience periods of remission and relapse. Early intervention and ongoing support are crucial for managing the condition. Stigma surrounding schizophrenia persists, highlighting the importance of education and understanding to promote empathy and effective mental health care.

How did the researchers find this correlation? Different from other studies, the team took acute respiratory distress syndrome (ARDS) and COVID lab negative cohorts as control groups to accurately gauge the impact of COVID on SSPD. Data from 19,344,698 patients were methodically filtered to create propensity-matched cohorts: ARDS, Covid-positive, and Covid-negative. They analyzed the hazard rate of new-onset SSPD across three distinct time intervals: 0-21 days, 22-90 days, and beyond 90 days post-infection. COVID positive patients consistently exhibited a heightened hazard ratio across all intervals, the findings showed. These are notably higher than both ARDS and Covid-19 lab-negative patients, the team said. Intriguingly, our data indicated that younger individuals face a heightened risk of SSPD after contracting Covid-19, a trend not observed in the ARDS and Covid-negative groups, they added.

Yoga asanas to reduce stress and anxiety

Visit link:

COVID increases risk of schizophrenia? Read what a new study has found - IndiaTimes

MLB partners with EPIC, Entain Foundation to educate Minor League players on gambling harm – Yogonet International

Major League Baseball (MLB)has partnered with EPIC Global SolutionsandEntain Foundation U.S.to enhance its educational efforts aimed at Minor League playersregarding the prevention of gambling-related harm.

EPIC will provide lived experience educational sessions focusing on responsible gaming and mental health for Minor League players and other selected MLB staff members. Meanwhile, Entain Foundation U.S., Entain's non-profit subsidiary, will offer financial support and additional resources for conducting these sessions.

"We believe that EPIC's impressive program facilitators, including an ex-minor leaguer, will communicate critical insights on gambling harm prevention in relatable and compelling ways," said Quest Meeks, Vice President, Sports Betting & Compliance at MLB.

"Our younger minor league players in particular are coming into the league at a time when mobile sports betting is an increasingly prominent part of the sports ecosystem. We want to help those players avoid gambling-related pitfalls that can derail not only their careers, but also their day-to-day lives more generally."

"We are pleased to be able to support baseball to take a proactive stance on player protection against gambling-related harm through our innovative lived experience approach, sharing the stories of those who have experienced gambling disorder firsthand," said Ben McGregor, director of sports partnerships at EPIC Global Solutions.

"Working with such an iconic American institution provides a unique opportunity to not only help the players connected to every franchise, but also the wider supporter base across the country, who can learn more about the potential effects of gambling harm through the increased profile this program will generate. We thank Major League Baseball and Entain Foundation U.S. for providing this platform for wider awareness."

This new three-way collaboration expands the ongoing relationship between EPIC Global Solutions and Entain Foundation U.S., to educate the public on preventing gambling-related harm. Entain Foundation U.S. already funds educational and awareness programs about gambling issues for professional and college athletes, coaches, and teams across the United States, as well as various sports organizations.

"Entain Foundation U.S. is proud to support EPIC Risk Management's effort to educate the Major League Baseball community about problem gambling," saidMartin Lycka, Entain's Senior Vice President for American Regulatory Affairs and Responsible Gambling and Trustee of Entain Foundation U.S.

"We must take a preventative approach to gambling harm, particularly those involved in sports, so educating the baseball community on responsible gambling practices is a critical measure," he added.

The delivery model is expected to commence in 2024, when EPIC will visit Minor League teams during Spring Training.

Read more:

MLB partners with EPIC, Entain Foundation to educate Minor League players on gambling harm - Yogonet International

Prostate Cancer in the Caribbean | Article – Cureus

Specialty

Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and Public Health Family Medicine Forensic Medicine Gastroenterology General Practice Genetics Geriatrics Health Policy Hematology HIV/AIDS Hospital-based Medicine I'm not a medical professional. Infectious Disease Integrative/Complementary Medicine Internal Medicine Internal Medicine-Pediatrics Medical Education and Simulation Medical Physics Medical Student Nephrology Neurological Surgery Neurology Nuclear Medicine Nutrition Obstetrics and Gynecology Occupational Health Oncology Ophthalmology Optometry Oral Medicine Orthopaedics Osteopathic Medicine Otolaryngology Pain Management Palliative Care Pathology Pediatrics Pediatric Surgery Physical Medicine and Rehabilitation Plastic Surgery Podiatry Preventive Medicine Psychiatry Psychology Pulmonology Radiation Oncology Radiology Rheumatology Substance Use and Addiction Surgery Therapeutics Trauma Urology Miscellaneous

Excerpt from:

Prostate Cancer in the Caribbean | Article - Cureus